Skip to content

The effect of Shatavari Guda and Kushmandaka Rasayana in the management of Heavy Menstrual Bleeding

AN OPEN LABEL RANDOMIZED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFECT OF SHATAVARI GUDA AND KUSHMANDAKA RASAYANA IN HEAVY MENSTRUAL BLEEDING - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087715
Enrollment
40
Registered
2025-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

Dr Raut Deepali Lahu
Lead Sponsor
JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) SUBJECTS FULFILLING THE DIAGNOSTIC CRITERIA 2) SUBJECTS WITH AGE GROUP 15 TO 45 YEARS 3) SUBJECTS WITH HEMOGLOBIN MORE THAN EQUAL TO 10 GRAMS

Exclusion criteria

Exclusion criteria: 1) Subjects with IUCD. 2) Subjects on oral Contraceptive pills. 3) Benign and malignant growth in reproductive organs. 4) Subjects with K/C/O metabolic and systemic disorders like Diabetes mellitus, Thyroid disorder, Hypertension. 5) Subjects with miscarriage/active bleeding followed by abortion. 6) K/C/O Coagulation Disorder, H/O previous thrombosis. 7) Lactating women.

Design outcomes

Primary

MeasureTime frame
bleeding will be controlledTimepoint: 3 months of continuous use will help in controlling heavy menstrual bleeding

Secondary

MeasureTime frame
loss of blood due to heavy cycles leads to anemia, which can be preventedTimepoint: 3 months regular use

Countries

India

Contacts

Public ContactDr Raut Deepali Lahu

JSS Ayurveda Medical College And Hospital mysuru

tejteju9@gmail.com8762409110

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026